212 related articles for article (PubMed ID: 18604640)
21. Antitrichomonas IgG, IgM, IgA, and IgG subclass responses in human intravaginal trichomoniasis.
Kaur S; Khurana S; Bagga R; Wanchu A; Malla N
Parasitol Res; 2008 Jul; 103(2):305-12. PubMed ID: 18437425
[TBL] [Abstract][Full Text] [Related]
22. Expression of a novel cell surface lipophosphoglycan-like glycoconjugate in Trypanosoma cruzi epimastigotes.
Singh BN; Lucas JJ; Beach DH; Costello CE
J Biol Chem; 1994 Sep; 269(35):21972-82. PubMed ID: 8071317
[TBL] [Abstract][Full Text] [Related]
23. Trichomonas vaginalis-induced epithelial monolayer disruption and human immunodeficiency virus type 1 (HIV-1) replication: implications for the sexual transmission of HIV-1.
Guenthner PC; Secor WE; Dezzutti CS
Infect Immun; 2005 Jul; 73(7):4155-60. PubMed ID: 15972505
[TBL] [Abstract][Full Text] [Related]
24. Production of interleukin-8 by human neutrophils stimulated with Trichomonas vaginalis.
Ryu JS; Kang JH; Jung SY; Shin MH; Kim JM; Park H; Min DY
Infect Immun; 2004 Mar; 72(3):1326-32. PubMed ID: 14977935
[TBL] [Abstract][Full Text] [Related]
25. [Clinico-experimental study of local humoral immunity of the vagina in human cases of trichomoniasis].
Voiculescu C; Rogoz S; Marx M
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1985; 30(1):49-56. PubMed ID: 3890111
[No Abstract] [Full Text] [Related]
26. Impact of T. vaginalis infection on innate immune responses and reproductive outcome.
Fichorova RN
J Reprod Immunol; 2009 Dec; 83(1-2):185-9. PubMed ID: 19850356
[TBL] [Abstract][Full Text] [Related]
27. MALDI-TOF mass spectrometry as a potential tool for Trichomonas vaginalis identification.
Calderaro A; Piergianni M; Montecchini S; Buttrini M; Piccolo G; Rossi S; Arcangeletti MC; Medici MC; Chezzi C; De Conto F
BMC Infect Dis; 2016 Jun; 16():261. PubMed ID: 27282151
[TBL] [Abstract][Full Text] [Related]
28. Trichomonas vaginalis infection induces vaginal CD4+ T-cell infiltration in a mouse model: a vaccine strategy to reduce vaginal infection and HIV transmission.
Smith JD; Garber GE
J Infect Dis; 2015 Jul; 212(2):285-93. PubMed ID: 25616405
[TBL] [Abstract][Full Text] [Related]
29. [Prevalence of Trichomonas vaginalis Donné in women of Lódź population in 1955-1999 years].
Kurnatowska A; Mamos AR
Wiad Parazytol; 2001; 47 Suppl 1():9-12. PubMed ID: 16897945
[TBL] [Abstract][Full Text] [Related]
30. Preliminary studies on target antigens for the diagnosis of Trichomonas vaginalis infection.
Deng HY; Lee JC; Chou SC; Wang GR
J Microbiol Immunol Infect; 1999 Mar; 32(1):14-20. PubMed ID: 11561565
[TBL] [Abstract][Full Text] [Related]
31. Proliferative response of human lymphocytes to secretory and cellular antigens of Trichomonas vaginalis.
Mason PR; Patterson BA
J Parasitol; 1985 Jun; 71(3):265-8. PubMed ID: 3874274
[TBL] [Abstract][Full Text] [Related]
32. Identification of Trichomonas vaginalis cysteine proteases that induce apoptosis in human vaginal epithelial cells.
Sommer U; Costello CE; Hayes GR; Beach DH; Gilbert RO; Lucas JJ; Singh BN
J Biol Chem; 2005 Jun; 280(25):23853-60. PubMed ID: 15843376
[TBL] [Abstract][Full Text] [Related]
33. Leishmania lipophosphoglycan activates the transcription factor activating protein 1 in J774A.1 macrophages through the extracellular signal-related kinase (ERK) and p38 mitogen-activated protein kinase.
Balaraman S; Singh VK; Tewary P; Madhubala R
Mol Biochem Parasitol; 2005 Jan; 139(1):117-27. PubMed ID: 15610826
[TBL] [Abstract][Full Text] [Related]
34. Antitrichomonal antibody in the vaginal secretions of women infected with T. vaginalis.
Ackers JP; Lumsden WH; Catterall RD; Coyle R
Br J Vener Dis; 1975 Oct; 51(5):319-23. PubMed ID: 1081423
[TBL] [Abstract][Full Text] [Related]
35. The structure of Leishmania major amastigote lipophosphoglycan.
Moody SF; Handman E; McConville MJ; Bacic A
J Biol Chem; 1993 Sep; 268(25):18457-66. PubMed ID: 8360147
[TBL] [Abstract][Full Text] [Related]
36. Detection of Chlamydia trachomatis and Trichomonas vaginalis in the vaginal introitus, posterior vagina, and endocervix by polymerase chain reaction.
Jeremias J; Tolbert V; Witkin SS
Methods Mol Biol; 1998; 92():227-37. PubMed ID: 9664518
[No Abstract] [Full Text] [Related]
37. Trichomonas vaginalis infection in symbiosis with Trichomonasvirus and Mycoplasma.
Fichorova R; Fraga J; Rappelli P; Fiori PL
Res Microbiol; 2017; 168(9-10):882-891. PubMed ID: 28366838
[TBL] [Abstract][Full Text] [Related]
38. Trichomonas vaginalis: in vitro phagocytosis of lactobacilli, vaginal epithelial cells, leukocytes, and erythrocytes.
Rendón-Maldonado JG; Espinosa-Cantellano M; González-Robles A; Martínez-Palomo A
Exp Parasitol; 1998 Jun; 89(2):241-50. PubMed ID: 9635448
[TBL] [Abstract][Full Text] [Related]
39. [Pathology and clinical aspects of human Trichomonas vaginalis infections].
Korte W; Senft HH
Hippokrates; 1976 May; 47(2):103-22. PubMed ID: 1085769
[No Abstract] [Full Text] [Related]
40. T. vaginalis Infection Is Associated with Increased IL-8 and TNFr1 Levels but with the Absence of CD38 and HLADR Activation in the Cervix of ESN.
Jarrett OD; Brady KE; Modur SP; Plants J; Landay AL; Ghassemi M; Golub ET; Spear GT; Novak RM
PLoS One; 2015; 10(6):e0130146. PubMed ID: 26083468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
